Showing results (151-160 of 931) with videos related to
Sort By:
Pageof 94
The Journal of the American Academy of Orthopaedic Surgeons|December 22, 2022
Risk of Revision Shoulder Arthroplasty After Anatomic and Reverse Total Shoulder ArthroplastyHolt S Cutler, Josh DeClercq, Gregory D Ayers, et al.Plant Science : an International Journal of Experimental Plant Biology|February 11, 2023
OsCRY2 and OsFBO10 co-regulate photomorphogenesis and photoperiodic flowering in indica riceShipra Singh, Satyam Vergish, Nitin Jain, et al.Surgery|May 1, 2004
Laparoscopic appendectomy in the elderlyUlrich Guller, Nitin Jain, Eric D Peterson, et al.International Journal of Hematology|September 4, 2009
Cytogenetic abnormalities in essential thrombocythemia at presentation and transformationMatjaz Sever, Hagop Kantarjian, Sherry Pierce, et al.Clinical Lymphoma, Myeloma & Leukemia|July 19, 2025
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Can Be Treated With Chemotherapy-Free Regimens Without TransplantFadi G Haddad, Hagop Kantarjian, Jayastu Senapati, et al.Clinical Imaging|November 24, 2020
A review of commonly performed bariatric surgeries: Imaging features and its complicationsDarshan Gandhi, Umesha Boregowda, Pranav Sharma, et al.Journal of Indian Association of Pediatric Surgeons|December 18, 2024
Spontaneous Intrathoracic Rupture of Abdominal Neuroblastoma in a 2-year-old Child: A Rare Case ReportSimmi K Ratan, Md Fahim Ahmad, Nitin Jain, et al.Cancer|October 12, 2018
Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvageElias Jabbour, Koji Sasaki, Farhad Ravandi, et al.Blood|March 31, 2021
Acalabrutinib in treatment-naive chronic lymphocytic leukemiaJohn C Byrd, Jennifer A Woyach, Richard R Furman, et al.The Lancet. Haematology|December 4, 2018
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 studyElias Jabbour, Nicholas J Short, Farhad Ravandi, et al.Pageof 94